Anterior gradient protein: Difference between revisions
No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
(27 intermediate revisions by 5 users not shown) | |||
Line 1: | Line 1: | ||
== Anterior Gradient Protein 2 == | == Anterior Gradient Protein 2 == | ||
<StructureSection load='2LNS' size='350' side='right' caption='residues 41-175 of AGR2 in dimer form (PDB entry [[2lns]])' scene='87/872187/Agr2_full/1'> | <StructureSection load='2LNS' size='350' side='right' caption='residues 41-175 of AGR2 in dimer form (PDB entry [[2lns]])' scene='87/872187/Agr2_full/1'> | ||
__TOC__ | |||
==Function== | |||
[https://www.uniprot.org/uniprot/AGR2_HUMAN AGR2_HUMAN] | [https://www.uniprot.org/uniprot/AGR2_HUMAN AGR2_HUMAN] | ||
Originally discovered in Xenopus laevis as a cement gland differentiation regulator <ref>31644305</ref>, <scene name='87/872187/Agr2_full/1'>Anterior Gradient Protein</scene> (AGR2) in humans is a protein chaperone involved in proteostasis, mainly for proteins expressed in epithelial cells, such as in the esophagus or lungs<ref> | Originally discovered in Xenopus laevis as a cement gland differentiation regulator <ref>PMID: 31644305</ref>, <scene name='87/872187/Agr2_full/1'>Anterior Gradient Protein 2</scene> (AGR2) in humans is a protein chaperone ([[chaperones]]) involved in '''proteostasis''', mainly for proteins expressed in epithelial cells, such as in the esophagus or lungs<ref>PMID:33005802</ref>. AGR2, composed of 175 amino acids, belongs to the protein disulfide isomerase family ([https://www.uniprot.org/uniprot/P07237 PDI]). | ||
== Structural highlights == | == Structural highlights == | ||
This protein contains various remarkable domains which can be visualized in the | This protein contains various remarkable domains which can be visualized in the interactive model<ref>PMID:33005802</ref>. | ||
'''- an unfolded NH2 terminal sequence with a peptide signal from the first to the 21st amino acid.''' | |||
'''- an active pseudo-thioredoxin domain (CXXS) from the <scene name='87/872187/Agr2_cxxs/2'>81st to the 84th amino acid</scene>. | |||
Called “pseudo” because there is only one active cysteine residue (<scene name='87/872187/Agr2_c81/2'>C81</scene>) | Called “pseudo” because there is only one active cysteine residue (<scene name='87/872187/Agr2_c81/2'>C81</scene>) | ||
''' - a terminal COOH sequence with a KTEL motif from the <scene name='87/872187/Agr2_cter/1'>172nd to the last amino acid.</scene>''''' | |||
Moreover, this protein can be found as a monomer or a dimer, thanks to a specific motif which is EALYK between the <scene name='87/872187/Agr2_dim/1'>60th and the 64th amino acids</scene>. There are intermolecular salt bridges involving E60 and K64, in order to fix the second monomer. The CXXS domain is on the opposite side to avoid any disulfide exchange. Nevertheless, the dimeric structure is oxidation-dependent which means that C81 is necessary. | Moreover, this protein can be found as a monomer or a dimer, thanks to a specific motif which is '''EALYK''' between the <scene name='87/872187/Agr2_dim/1'>60th and the 64th amino acids</scene>. There are intermolecular [[salt bridges]] involving E60 and K64, in order to fix the second monomer. The''' CXXS domain''' is on the opposite side to avoid any disulfide exchange. Nevertheless, the dimeric structure is oxidation-dependent which means that C81 is necessary<ref>PMID: 31644305</ref>. | ||
== Functions == | == Functions == | ||
AGR2 does not have the same roles if it is found in the extracellular matrix, or the intracellular milieu. According to the patterns found in N-ter and C-ter it seems obvious that AGR2 is a protein intended to reside in the ER, so inside the cells. Indeed, N-ter sequence directs the import of AGR2 into the ER and is responsible for the cell adhesion properties of AGR2, and the C-ter sequence prevents the AGR2 from being exported out of the ER. Within the latter, AGR2 allows the folding of nascent proteins in the ER, in order to mature them, through its CXXS domain, which catalyzes the formation and isomerization of disulfide bonds during protein folding. This protein mainly allows the folding of cysteine-rich proteins, such as the protein coded by the gene MUC2, by forming disulfide bridges. However, it happens that AGR2 is found outside the ER despite its function as a disulfide isomerase and its C-ter sequence, the reason remains unclear. In a cancerous medium such as serum or urine, extracellular AGR2 is often found in large quantities. | AGR2 does not have the same roles if it is found in the extracellular matrix, or the intracellular milieu. According to the patterns found in N-ter and C-ter it seems obvious that AGR2 is a protein intended to reside '''in the ER''' ([[ER-resident protein]]), so inside the cells. Indeed, N-ter sequence directs the import of AGR2 into the ER and is responsible for the cell adhesion properties of AGR2, and the C-ter sequence prevents the AGR2 from being exported out of the ER. Within the latter, AGR2 allows the folding of nascent proteins in the ER, in order to mature them, through its CXXS domain<ref>PMID:12237451</ref>, which catalyzes the formation and isomerization of '''disulfide bonds''' during protein folding<ref>PMID: 14503871 </ref>. This protein mainly allows the folding of cysteine-rich proteins, such as the protein coded by the gene MUC2 ([[6rbf]]), by forming disulfide bridges<ref>PMID:33005802</ref>. However, it happens that AGR2 is found outside the ER despite its function as a disulfide isomerase and its C-ter sequence, the reason remains unclear. In a cancerous medium such as serum or urine, extracellular AGR2 is often found in large quantities<ref>PMID:27240165</ref>. | ||
== Disease == | == Disease == | ||
Different links between this protein and the appearance of some pathologies such as cancers or inflammatory diseases have been highlighted. | |||
In fact, it has been possible to deduce that its involvement in proteostasis may play an important role in the '''development of tumors''' and more specifically in the multiplication of abnormal or mutated proteins in tumor cells. | |||
This protein plays a role in hormone-dependent cancers such as breast and prostate cancer. Indeed, AGR2 is not constitutive and its expression is regulated by signals. In this regard, ARG2 expression is detected in women with breast cancer, and their prognosis is poor. | |||
Furthermore, in a study on inflammatory diseases, it was found that a mutation on (<scene name='87/872187/Agr2_c81/2'>C81</scene>) (which is part of the CXXS domain) in AGR2 causes an alteration in the interactions with [https://onlinelibrary.wiley.com/doi/abs/10.1111/imr.12182 mucin proteins]. | |||
In this pathway, the overexpression of AGR2 can cause an '''overexpression of mucus''' which, in breast cancer, participates in the proliferation of cancer cells and metastasis. | |||
The AGR2 protein can form complexes with [https://www.uniprot.org/uniprot/Q9Y230 Reptin] ([[2cqa]]) which is recognized as an '''anti-oncogene'''. However, it binds more easily when the protein is in dimeric form. Thus, a mutation on (<scene name='87/872187/Agr2_e60/2'>E60</scene>) site, giving the protein a monomeric form, would reduce cancer repression by Reptin. | |||
Finally, the expression of AGR2 in breast cancer patients confers chemoresistance to cancer cell growth inhibitors such as Tamoxifen, the mechanism is still unclear.<ref>PMID: 25937245</ref> | |||
== 3D Structures of anterior gradient protein == | |||
Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | |||
[[2lns]] - hAGR2 - human - NMR<br /> | |||
[[2lnt]] - hAGR2 (mutant) - NMR<br /> | |||
[[3ph9]] - hAGR3<br /> | |||
== References == | == References == | ||
<references/> | <references/> | ||
</StructureSection> | |||
[[Category:Topic Page]] |